About Dynex Technologies
Dynex Technologies is a Healthcare company based in Chantilly (United States) founded in 2014, and was acquired by Telegraph Hill Partners in March 2017. It operates as a microplate processing systems are developed for healthcare immunoassay applications. Its chief executive is David Sholehvar. Dynex Technologies offers products and services including DS2 System, DSX System, Agility System, 2-Plate System, and 4-Plate System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Lab Automation. Its legal entity is DYNEX TECHNOLOGIES, INC. Its competitors include Cerillo, BMG Labtech, Oxoprobics Biosciences and Phylumtech; 1 of its 4 listed competitors has raised funding.
Company details
Dynex Technologies was founded in 2014 and is headquartered in Chantilly, United States. Microplate processing systems are produced by the company for use in healthcare, particularly for ELISA immunoassays. Products such as DS2, DSX, and the Agility system are offered, enabling full automation through features like robotic arms for pipetting and plate transport. Proprietary Smartkits are provided to shorten assay times, alongside consumables for the overall process.
- Headquarters Chantilly, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website dynextechnologies.com
- Social LinkedIn X
- Acquired by Telegraph Hill Partners (Mar 2017)
- Legal Name Dynex Technologies, Inc..
- Investors
- Acquired byTelegraph Hill Partners
(Mar 2017)
Products & Services of Dynex Technologies
Dynex Technologies offers a comprehensive portfolio of products and services, including DS2 System, DSX System, Agility System, 2-Plate System, and 4-Plate System.
Automates ELISA testing to improve laboratory productivity and accuracy.
Offers comprehensive automation for reliable diagnostic processing.
Enables simultaneous runs of multiple assays with regulatory-compliant software.
Provides basic automated testing for smaller laboratory operations.
Supports efficient ELISA processing for medium-scale diagnostics.
Facilitates high-throughput testing with minimal human intervention.
Investors in Dynex Technologies
Dynex Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science, medical device and healthcare companies | – | thpartners.net | San Francisco, United States |
Investor details for Dynex Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dynex Technologies
1 people are tracked at Dynex Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Sholehvar | CEO | Leadership |
Complete people profiles for Dynex Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dynex Technologies
2 dated milestones of Dynex Technologies across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Dynex Technologies is founded.
- Exit Acquired by Telegraph Hill Partners.
Competitors of Dynex Technologies
Dynex Technologies has 4 listed competitors in our database, 1 of them funded. They include Cerillo, BMG Labtech, Oxoprobics Biosciences and Phylumtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cerillo.bio | 2016 | Charlottesville, United States | $3.31M | 8 | Microplate reader systems for laboratory instruments are provided by Cerillo. | |
| bmglabtech.com | 1989 | Ortenberg, Germany | – | 24 | Multi-mode microplate readers are developed for life sciences applications. | |
| oxoprobics.com | 2014 | Madrid, Spain | – | – | Microplate readers for research applications are provided by Oxoprobics Biosciences. | |
| phylumtech.com | 2009 | Santa Fe, Argentina | – | – | Drug validation products and cloud-based testing services are developed. |
Detailed competitors of Dynex Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dynex Technologies
The website of Dynex Technologies (dynextechnologies.com) receives about 4.8K visits a month.
- Monthly visits4.8K
▲ 45% vs previous month
Websites whose visitors overlap most with Dynex Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
alerecoag.com | alerecoag.com | 100% | – | – | – |
| drg-diagnostics.de | 99% | – | – | View details | |
gesundheitsindustrie-bw.de | gesundheitsindustrie-bw.de | 66% | – | #1,750,575 | – |
| dynexsemi.com | 33% | 7.2K | #3,035,888 | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Dynex Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dynex Technologies
Complete news archive for Dynex Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dynex Technologies
Dynex Technologies was founded in 2014.
Dynex Technologies is headquartered in Chantilly, United States. It is registered at Chantilly, Virginia, United States.
David Sholehvar is the current CEO of Dynex Technologies.
Dynex Technologies was founded in 2014 and is headquartered in Chantilly, United States. Microplate processing systems are produced by the company for use in healthcare, particularly for ELISA immunoassays. Products such as DS2, DSX, and the Agility system are offered, enabling full automation through features like robotic arms for pipetting and plate transport. Proprietary Smartkits are provided to shorten assay times, alongside consumables for the overall process.
Dynex Technologies's top competitors include Cerillo, BMG Labtech and Oxoprobics Biosciences.
Dynex Technologies offers DS2 System, DSX System, Agility System, 2-Plate System, and 2 more products and services.
Dynex Technologies has 1 investor. Key investors include Telegraph Hill Partners.
Dynex Technologies operates through Dynex Technologies, Inc...
Yes. Dynex Technologies was acquired by Telegraph Hill Partners in March 2017.